|
Valoración DCF de OptHea Limited (OPT)
AU | Healthcare | Biotechnology | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Opthea Limited (OPT) Bundle
¡Explore las perspectivas financieras de Opthea Limited (OPT) con nuestra calculadora DCF fácil de usar! Ingrese sus suposiciones con respecto a las tasas de crecimiento, los márgenes de beneficio y los gastos para calcular el valor intrínseco de Opthea Limited (OPT) e informar sus decisiones de inversión.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .1 | .1 | .1 | .1 | .1 | .1 | .1 | .1 | .1 | .1 |
| Revenue Growth, % | 0 | -36.96 | 35.95 | 28.88 | -22.65 | 1.31 | 1.31 | 1.31 | 1.31 | 1.31 |
| EBITDA | -15.5 | -32.9 | -82.8 | -138.8 | -124.4 | -.1 | -.1 | -.1 | -.1 | -.1 |
| EBITDA, % | -17079.2 | -57455.77 | -106489.56 | -138554.61 | -160443.72 | -100 | -100 | -100 | -100 | -100 |
| Depreciation | .1 | .1 | .1 | .1 | .1 | .1 | .1 | .1 | .1 | .1 |
| Depreciation, % | 98.71 | 155.46 | 86.43 | 93.38 | 82.64 | 92.23 | 92.23 | 92.23 | 92.23 | 92.23 |
| EBIT | -15.6 | -32.9 | -82.9 | -138.9 | -124.4 | -.1 | -.1 | -.1 | -.1 | -.1 |
| EBIT, % | -17177.91 | -57611.24 | -106575.99 | -138647.99 | -160526.36 | -100 | -100 | -100 | -100 | -100 |
| Total Cash | 38.6 | 97.9 | 40.4 | 83.3 | 107.2 | .1 | .1 | .1 | .1 | .1 |
| Total Cash, percent | .0 | .2 | .1 | .1 | .1 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 5.5 | .0 | .0 | 4.1 | 7.4 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 6043.57 | 0 | 0 | 4072.22 | 9484.89 | 60 | 60 | 60 | 60 | 60 |
| Inventories | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 0 | 0.00108718 | 0 | 0.000620489815 | 0 | 0.000341534173 | 0.000341534173 | 0.000341534173 | 0.000341534173 | 0.000341534173 |
| Accounts Payable | 2.5 | 1.5 | 7.1 | 11.1 | 23.7 | .1 | .1 | .1 | .1 | .1 |
| Accounts Payable, % | 2778.61 | 2628.5 | 9118.3 | 11071.39 | 30529.44 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | -2.51 | -18.51 | -18.65 | -20.25 | -26.86 | -17.36 | -17.36 | -17.36 | -17.36 | -17.36 |
| Tax Rate, % | 4.1 | 4.1 | 4.1 | 4.1 | 4.1 | 4.1 | 4.1 | 4.1 | 4.1 | 4.1 |
| EBITAT | -10.3 | -29.7 | -77.6 | -133.4 | -119.3 | -.1 | -.1 | -.1 | -.1 | -.1 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -13.2 | -25.2 | -72.0 | -133.4 | -110.0 | -16.3 | .0 | .0 | .0 | .0 |
| WACC, % | 12.25 | 13.38 | 13.54 | 13.65 | 13.65 | 13.3 | 13.3 | 13.3 | 13.3 | 13.3 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -14.4 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | -14 | |||||||||
| Net Debt | -19 | |||||||||
| Equity Value | 5 | |||||||||
| Diluted Shares Outstanding, MM | 80 | |||||||||
| Equity Value Per Share | 0.06 |
What You Will Receive
- Comprehensive Financial Model: Utilizes Opthea Limited’s (OPT) actual data for accurate DCF valuation.
- Complete Forecast Flexibility: Modify revenue growth, profit margins, WACC, and other essential factors.
- Real-Time Calculations: Instant updates allow you to view results immediately as adjustments are made.
- Professional-Grade Template: A polished Excel file crafted for high-quality valuation presentations.
- Adaptable and Reusable: Designed for versatility, enabling multiple uses for thorough forecasting.
Key Features
- Comprehensive Historical Data: Opthea Limited’s (OPT) past financial statements and pre-filled projections.
- Customizable Parameters: Adjust WACC, tax rates, revenue growth, and EBITDA margins to fit your analysis.
- Real-Time Valuation: Instantly view the recalculated intrinsic value of Opthea Limited (OPT).
- Visual Insights: Dashboard charts present valuation outcomes and essential metrics clearly.
- Designed for Precision: A reliable tool tailored for analysts, investors, and finance professionals.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review pre-entered Opthea Limited (OPT) data (historical and projected).
- Step 3: Adjust key assumptions (yellow cells) based on your analysis.
- Step 4: View automatic recalculations for Opthea Limited’s intrinsic value.
- Step 5: Use the outputs for investment decisions or reporting.
Why Choose Opthea Limited (OPT)?
- Innovative Solutions: Benefit from cutting-edge therapies tailored for eye diseases.
- Proven Efficacy: Clinical trials demonstrate the effectiveness of our treatments.
- Patient-Centric Approach: We prioritize the needs and experiences of our patients.
- Expert Team: Our professionals are leaders in ophthalmology and biotechnology.
- Strong Commitment: Dedicated to advancing research and improving patient outcomes.
Who Should Use This Product?
- Individual Investors: Make informed decisions about buying or selling Opthea Limited (OPT) stock.
- Financial Analysts: Streamline valuation processes with ready-to-use financial models specific to Opthea Limited (OPT).
- Consultants: Deliver professional valuation insights on Opthea Limited (OPT) to clients quickly and accurately.
- Business Owners: Understand how biopharmaceutical companies like Opthea Limited (OPT) are valued to guide your own strategy.
- Finance Students: Learn valuation techniques using real-world data and scenarios related to Opthea Limited (OPT).
What the Template Contains
- Pre-Filled Data: Includes Opthea Limited’s historical financials and forecasts.
- Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
- Key Financial Ratios: Analyze Opthea Limited’s profitability, efficiency, and leverage.
- Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
- Clear Dashboard: Charts and tables summarizing key valuation results.